Wipro to implement Independent Health’s Medicare prescription payment plan platform
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
Around 7% of the Indian population suffers from IBS
Aurigene.AI is an end-to-end solution for small molecule drug discovery
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
The investment will catalyse various components of the IndiaAI Mission
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
These digital avenues have not only revolutionized patient care but also opened up new opportunities for HCPs to build thought leadership in their respective fields
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Sirius JV will be owned 51% by Sirius and 49% by Adani
Subscribe To Our Newsletter & Stay Updated